EUVIMEDEUVIMED entdecken
Crossref

Toward a Better Understanding of NRF2/NFE2L2 and BCRP/ABCG2 in Therapy Resistance in Cancer

Steffanus Pranoto Hallis, Beam Ju Go, Jun Min Yoo, Geun Hee Cho, Mi-Kyoung Kwak

Drug Targets and Therapeutics · 30.09.2023 · 2 (2) · 111-123

DOI: 10.58502/dtt.23.0021 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Targets and Therapeutics, erschienen am 30.09.2023. Verfasst von Steffanus Pranoto Hallis und 4 weiteren Autor:innen. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 119 Literaturangaben. Gefördert von: National Research Foundation of Korea, Ministry of Science and ICT, South Korea.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Förderung

  • National Research Foundation of Korea
  • Ministry of Science and ICT, South Korea

Zitieren

APA

Hallis, S. P., Go, B. J., Yoo, J. M., Cho, G. H., & Kwak, M. (2023). Toward a Better Understanding of NRF2/NFE2L2 and BCRP/ABCG2 in Therapy Resistance in Cancer. Drug Targets and Therapeutics, 2(2), 111-123. https://doi.org/10.58502/dtt.23.0021

Vancouver

Hallis SP, Go BJ, Yoo JM, Cho GH, Kwak M. Toward a Better Understanding of NRF2/NFE2L2 and BCRP/ABCG2 in Therapy Resistance in Cancer. Drug Targets and Therapeutics. 2023;2(2):111-123. doi:10.58502/dtt.23.0021

BibTeX
@article{Hallis2023,
  author = {Hallis, Steffanus Pranoto and Go, Beam Ju and Yoo, Jun Min and Cho, Geun Hee and Kwak, Mi-Kyoung},
  title = {Toward a Better Understanding of NRF2/NFE2L2 and BCRP/ABCG2 in Therapy Resistance in Cancer},
  journal = {Drug Targets and Therapeutics},
  year = {2023},
  volume = {2},
  number = {2},
  pages = {111--123},
  doi = {10.58502/dtt.23.0021}
}
Kostenlos starten →